Findings

What do systematic reviews say?

2 questions · 4 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 25%Moderate 1 · 25%High 0 · 0%

Usual care with ivabradine vs Placebo, no intervention or usual care (with or without placebo)

Cardiovascular mortality · patients with chronic heart failure with preserved ejection fraction

2 findings from 1 review

Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 178 participants
Low
Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Usual care with ivabradine vs Placebo, no intervention or usual care (with or without placebo)

Cardiovascular mortality · adults (≥ 18 years of age) with a diagnosis of chronic heart failure with reduced ejection fraction (HFrEF)

Usual care with ivabradine showed no clear difference in mortality from cardiovascular causes ( compared with placebo, usual care, or no treatment (moderate certainty).

2 findings from 1 review

Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
RR 0.99 [0.88, 1.11]
3 studies · 17676 participants
Moderate
Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found